TrialDiabetes2026
LEAP2 Reduces Ad Libitum Food Intake and Attenuates Postprandial Glucose Excursions in Men With Obesity.
Anders Englund et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
2 papers cite it
this papercites it
TrialDiabetes2026
Anders Englund et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.